Aging
Navigate
Back to articleFigure 2(2 of 6)
100%
Figure 2
Figure 2.Estimation of the cumulative risk of patients with bone metastasis from NSCLC based on the following protective genotypes: (A) WNT2: rs6947329, (B) AXIN1: rs214252, (C) CTNNB1: rs1880481, (D) CTNNB1: rs4135385, (E) APC: rs454886, and (F) combined.